Page 8 - Read Online
P. 8

38         Conventional type 1 dendritic cells in protective antitumor immunity and its potential in hepatocellular
                        carcinoma
                        Chunfeng Qu, Kun Chen, Shao-Yan Cheng
                        Hepatoma Res 2020;6:38  http://dx.doi.org/10.20517/2394-5079.2020.12


           39         Stereotactic body radiation therapy for the management of HCC:
                        Jia-Xin Li, Hong Wu , Yong Zeng
                        Hepatoma Res 2020;6:39  http://dx.doi.org/10.20517/2394-5079.2020.13

           40         The advances in immunotherapy for hepatocellular carcinoma
                        Fan Zhang, Yumin Li
                        Hepatoma Res 2020;6:40  http://dx.doi.org/10.20517/2394-5079.2020.20

           41         β-catenin in intranuclear inclusions of hepatocellular carcinoma
                        Suzan Schwertheim, Holger Jastrow, Julia Kälsch, Thomas Herold, Sarah Theurer, Saskia Ting, Kurt Werner
                        Schmid, Hideo Andreas Baba
                        Hepatoma Res 2020;6:41  http://dx.doi.org/10.20517/2394-5079.2020.23


           42         Genetics of alcohol-related hepatocellular carcinoma - its role in risk prediction
                        Ken Liu, Gontran Verset, Eric Trepo, Devanshi Seth
                        Hepatoma Res 2020;6:42  http://dx.doi.org/10.20517/2394-5079.2020.25


           43         Comprehending the therapeutic effects of stereotactic body radiation therapy for small hepatocellular
                        carcinomas based on imagings
                        Zhao-Chong Zeng, Jia Fan, Jian Zhou, Meng-Su Zeng, Yi-Xing Chen, Zhi-Feng Wu, Jing Sun, Jian-Ying Zhang,
                        Yong Hu, Qian-Qian Zhao
                        Hepatoma Res 2020;6:43  http://dx.doi.org/10.20517/2394-5079.2020.29


           44         Imaging assessment after SBRT for hepatocellular carcinoma
                        Connie Yip, Tiffany Priyanthi Hennedige, Gary J. R. Cook, Vicky Goh
                        Hepatoma Res 2020;6:44  http://dx.doi.org/10.20517/2394-5079.2020.30

           45         For dietary advice in end-stage liver cirrhosis resting metabolic rate should be measured, not estimated
                        Daphne Bot, Anneke Droop, Maarten E. Tushuizen, Bart van Hoek
                        Hepatoma Res 2020;6:45  http://dx.doi.org/10.20517/2394-5079.2020.62


           46         Contrast-enhanced ultrasonography with Sonazoid in hepatocellular carcinoma diagnosis
                        Yasunori Minami, Masatoshi Kudo
                        Hepatoma Res 2020;6:46  http://dx.doi.org/10.20517/2394-5079.2020.32


           47         Pathomolecular characterization of HCC in non-cirrhotic livers
                        Archana Rastogi
                        Hepatoma Res 2020;6:47  http://dx.doi.org/10.20517/2394-5079.2020.35
   3   4   5   6   7   8   9   10   11   12   13